 Cytokinetics, Incorporated NASDAQ:CYTK Q2 2022 Earnings Conference Call August 4, 2022 4:30 AM ET Company Participants Diane Weiser - SVP, Corporate Communications and Investor Relations Robert Blum - President And Chief Executive Officer Fady Malik - EVP, Research and Development Andrew Callos - EVP, Chief Commercial Officer Stuart Kupfer - SVP, Chief Medical Officer Robert Wong - VP, Chief Accounting Officer Ching Jaw - SVP, Chief Financial Officer Conference Call Participants Justin Kim - Oppenheimer Yasmeen Rahimi - Piper Sandler Michael Linden - Mizuho Group Joseph Pantginis - H.C. Wainwright Jason Butler - JMP Securities Charles Duncan - Cantor Rohit Bhasin - Needham Company Operator Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics Second Quarter 2022 Conference Call. 